A common polymorphism in the complement factor H gene (rs1061170, Y402H) is associated with a high risk of age-related macular degeneration (AMD). In the present study we hypothesized that healthy young subjects homozygous for the high-risk haplotype (CC) show abnormal choroidal blood flow (ChBF) regulation decades before potentially developing the disease. A total of 100 healthy young subjects were included in the present study, of which 4 subjects were excluded due to problems with genotyping or blood flow measurements. ChBF was measured continuously using laser Doppler flowmetry while the subjects performed isometric exercise (squatting) for 6 minutes. The increase in ChBF was less pronounced than the response in ocular perfusion pressure (OPP), indicating for some degree of choroidal blood flow regulation. Eighteen subjects were homozygous for C, 47 subjects were homozygous for T and 31 subjects were heterozygous (CT). The increase in OPP during isometric exercise was not different between groups. By contrast the increase in ChBF was more pronounced in subjects homozygous for the high risk C allele (p = 0.041). This was also evident from the pressure/flow relationship, where the increase in ChBF in homozygous C carriers started at lower OPPs as compared to the other groups. Our data indicate that the regulation of ChBF is abnormal in rs1061170 CC carriers. So far this polymorphism has been linked to age related macular degeneration (AMD) mainly via inflammatory pathways associated with the complement system dysfunction. Our results indicate that it could also be related to vascular factors that have been implicated in AMD pathogenesis.
References
[1]
Coleman AL, Yu F (2008) Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999. Ophthalmology 115: 18–25.
[2]
Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, et al. (2010) Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmol 10: 31.
[3]
Chen J, Smith LE (2012) Protective inflammasome activation in AMD. Nat Med 18: 658–660.
[4]
Boltz A, Lasta M, Schmidl D, Kaya S, Garhofer G, et al. (2010) Risk factors for age-related macular degeneration. Spektrum Der Augenheilkunde 24: 296–304.
[5]
Bergeron-Sawitzke J, Gold B, Olsh A, Schlotterbeck S, Lemon K, et al. (2009) Multilocus analysis of age-related macular degeneration. Eur J Hum Genet 17: 1190–1199.
[6]
Tong Y, Liao J, Zhang Y, Zhou J, Zhang H, et al. (2010) LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis. Mol Vis 16: 1958–1981.
[7]
Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, et al. (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29: 95–112.
[8]
Donoso LA, Vrabec T, Kuivaniemi H (2010) The role of complement Factor H in age-related macular degeneration: a review. Surv Ophthalmol 55: 227–246.
[9]
Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, et al (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308: 421–424.
[10]
Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. (2005) Complement factor H variant increases the risk of age-related macular degeneration. Science 308: 419–421.
[11]
Wegscheider BJ, Weger M, Renner W, Steinbrugger I, Marz W, et al. (2007) Association of complement factor H Y402H gene polymorphism with different subtypes of exudative age-related macular degeneration. Ophthalmology 114: 738–742.
[12]
Klein R, Knudtson MD, Lee KE, Klein BE (2009) Serum cystatin C level, kidney disease markers, and incidence of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol 127: 193–199.
[13]
Mullins RF, Russell SR, Anderson DH, Hageman GS (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J 14: 835–846.
[14]
Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, et al. (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20: 705–732.
[15]
Jylhava J, Eklund C, Jylha M, Hervonen A, Lehtimaki T, et al. (2009) Complement factor H 402His variant confers an increased mortality risk in Finnish nonagenarians: the Vitality 90+ study. Exp Gerontol 44: 297–299.
[16]
Jylhava J, Eklund C, Pessi T, Raitakari OT, Juonala M, et al. (2009) Genetics of C-reactive protein and complement factor H have an epistatic effect on carotid artery compliance: the Cardiovascular Risk in Young Finns Study. Clin Exp Immunol 155: 53–58.
[17]
Lundh von Leithner P, Kam JH, Bainbridge J, Catchpole I, Gough G, et al. (2009) Complement factor h is critical in the maintenance of retinal perfusion. Am J Pathol 175: 412–421.
[18]
Riva CE, Titze P, Hero M, Movaffaghy A, Petrig BL (1997) Choroidal blood flow during isometric exercises. Invest Ophthalmol Vis Sci 38: 2338–2343.
[19]
Luksch A, Polska E, Imhof A, Schering J, Fuchsjager-Mayrl G, et al. (2003) Role of NO in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci 44: 734–739.
[20]
Fuchsjager-Mayrl G, Luksch A, Malec M, Polska E, Wolzt M, et al. (2003) Role of endothelin-1 in choroidal blood flow regulation during isometric exercise in healthy humans. Invest Ophthalmol Vis Sci 44: 728–733.
[21]
Polska E, Luksch A, Schering J, Frank B, Imhof A, et al. (2003) Propranolol and atropine do not alter choroidal blood flow regulation during isometric exercise in healthy humans. Microvasc Res 65: 39–44.
[22]
Schmidl D, Garhofer G, Schmetterer L (2011) The complex interaction between ocular perfusion pressure and ocular blood flow – relevance for glaucoma. Exp Eye Res 93: 141–155.
[23]
Zhou J, Jang YP, Kim SR, Sparrow JR (2006) Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium. Proc Natl Acad Sci U S A 103: 16182–16187.
[24]
Machalinska A, Kawa MP, Marlicz W, Machalinski B (2012) Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosis. Acta Ophthalmol 90: 695–703.
[25]
Schaumberg DA, Christen WG, Buring JE, Glynn RJ, Rifai N, et al. (2007) High-sensitivity C-reactive protein, other markers of inflammation, and the incidence of macular degeneration in women. Arch Ophthalmol 125: 300–305.
[26]
Kardys I, Klaver CC, Despriet DD, Bergen AA, Uitterlinden AG, et al. (2006) A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. J Am Coll Cardiol 47: 1568–1575.
[27]
Volcik KA, Ballantyne CM, Braun MC, Coresh J, Mosley TH, et al. (2008) Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study. Am J Hypertens 21: 533–538.
[28]
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119: 1417–1436.
[29]
Klein ML, Francis PJ, Rosner B, Reynolds R, Hamon SC, et al. (2008) CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology 115: 1019–1025.
[30]
Ho L, van Leeuwen R, Witteman JC, van Duijn CM, Uitterlinden AG, et al. (2011) Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch Ophthalmol 129: 758–766.
[31]
Friedman E, Krupsky S, Lane AM, Oak SS, Friedman ES, et al. (1995) Ocular blood flow velocity in age-related macular degeneration. Ophthalmology 102: 640–646.
[32]
Grunwald JE, Hariprasad SM, DuPont J, Maguire MG, Fine SL, et al. (1998) Foveolar choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 39: 385–390.
[33]
Pauleikhoff D, Spital G, Radermacher M, Brumm GA, Lommatzsch A, et al. (1999) A fluorescein and indocyanine green angiographic study of choriocapillaris in age-related macular disease. Arch Ophthalmol 117: 1353–1358.
[34]
Ciulla TA, Harris A, Kagemann L, Danis RP, Pratt LM, et al. (2002) Choroidal perfusion perturbations in non-neovascular age related macular degeneration. Br J Ophthalmol 86: 209–213.
[35]
Uretmen O, Akkin C, Erakgun T, Killi R (2003) Color Doppler imaging of choroidal circulation in patients with asymmetric age-related macular degeneration. Ophthalmologica 217: 137–142.
[36]
Grunwald JE, Metelitsina TI, Dupont JC, Ying GS, Maguire MG (2005) Reduced foveolar choroidal blood flow in eyes with increasing AMD severity. Invest Ophthalmol Vis Sci 46: 1033–1038.
[37]
Metelitsina TI, Grunwald JE, DuPont JC, Ying GS (2006) Effect of systemic hypertension on foveolar choroidal blood flow in age related macular degeneration. Br J Ophthalmol 90: 342–346.
[38]
Pournaras CJ, Logean E, Riva CE, Petrig BL, Chamot SR, et al. (2006) Regulation of subfoveal choroidal blood flow in age-related macular degeneration. Invest Ophthalmol Vis Sci 47: 1581–1586.
[39]
Metelitsina TI, Grunwald JE, DuPont JC, Ying GS, Brucker AJ, et al. (2008) Foveolar choroidal circulation and choroidal neovascularization in age-related macular degeneration. Invest Ophthalmol Vis Sci 49: 358–363.
[40]
Boltz A, Luksch A, Wimpissinger B, Maar N, Weigert G, et al. (2010) Choroidal blood flow and progression of age-related macular degeneration in the fellow eye in patients with unilateral choroidal neovascularization. Invest Ophthalmol Vis Sci 51: 4220–4225.
[41]
Vinores SA, Xiao WH, Aslam S, Shen J, Oshima Y, et al. (2006) Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J Cell Physiol 206: 749–758.
[42]
Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, Rosner B, et al. (2009) Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci 50: 5818–5827.
[43]
Clark SJ, Bishop PN, Day AJ (2010) Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology. Biochem Soc Trans 38: 1342–1348.
[44]
Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HP, et al. (2011) Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 478: 76–81.
[45]
Thakkinstian A, Han P, McEvoy M, Smith W, Hoh J, et al. (2006) Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration. Hum Mol Genet 15: 2784–2790.
[46]
Zee RY, Diehl KA, Ridker PM (2006) Complement factor H Y402H gene polymorphism, C-reactive protein, and risk of incident myocardial infarction, ischaemic stroke, and venous thromboembolism: a nested case-control study. Atherosclerosis 187: 332–335.
[47]
Wolzt M, Schmetterer L, Rheinberger A, Salomon A, Unfried C, et al. (1995) Comparison of non-invasive methods for the assessment of haemodynamic drug effects in healthy male and female volunteers: sex differences in cardiovascular responsiveness. Br J Clin Pharmacol 39: 347–359.
[48]
Riva CE, Cranstoun SD, Grunwald JE, Petrig BL (1994) Choroidal blood flow in the foveal region of the human ocular fundus. Invest Ophthalmol Vis Sci 35: 4273–4281.
[49]
Geiser MH, Riva CE, Diermann U (1999) [Measuring choroid blood flow with a new confocal laser Doppler device]. Klin Monbl Augenheilkd 214: 285–287.
[50]
Geiser MH, Riva CE, Dorner GT, Diermann U, Luksch A, et al. (2000) Response of choroidal blood flow in the foveal region to hyperoxia and hyperoxia-hypercapnia. Curr Eye Res 21: 669–676.
[51]
Goverdhan SV, Hannan S, Newsom RB, Luff AJ, Griffiths H, et al. (2008) An analysis of the CFH Y402H genotype in AMD patients and controls from the UK, and response to PDT treatment. Eye (Lond) 22: 849–854.
[52]
Robinson F, Riva CE, Grunwald JE, Petrig BL, Sinclair SH (1986) Retinal blood flow autoregulation in response to an acute increase in blood pressure. Invest Ophthalmol Vis Sci 27: 722–726.
